T.C. Orton
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 11
- Cancer Research top 10%
- Small Animals top 5%
- Clinical Biochemistry top 5%
-
- Drug Transport and Resistance Mechanisms 5
- Cancer Treatment and Pharmacology 3
-
- Peroxisome Proliferator-Activated Receptors 3
- Pluripotent Stem Cells Research 3
- Ion channel regulation and function 3
-
- Hormonal Regulation and Hypertension 3
-
- Estrogen and related hormone effects 3
- Co-authors
- Oliver FlintThomas E. ElingM. AndersonR.D. PickettPeter GreavesGraham R. NunnJ.C. TophamRobert L. Fine
- Journals
- Carcinogenesis (6 papers)Journal of Pharmacology and Experimental Therapeutics (5 papers)Xenobiotica (3 papers)
- Partner nations
- United KingdomUnited StatesSingapore
In The Last Decade
T.C. Orton
37 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 111
- Pharmacology 292
- Cancer Research 271
- Health, Toxicology and Mutagenesis 205
- Small Animals 86
- Clinical Biochemistry 73
Countries citing papers authored by T.C. Orton
This map shows the geographic impact of T.C. Orton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.C. Orton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.C. Orton more than expected).
Fields of papers citing papers by T.C. Orton
This network shows the impact of papers produced by T.C. Orton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.C. Orton. The network helps show where T.C. Orton may publish in the future.
Co-authorship network
The 25 scholars most cited alongside T.C. Orton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 22 | |
| 2 | 1997 | 18 | |
| 3 | 1996 | 9 | |
| 4 | 1996 | 31 | |
| 5 | 1994 | 15 | |
| 6 | 1993 | 15 | |
| 7 | 1993 | 52 | |
| 8 | 1990 | 1 | |
| 9 | 1989 | 7 | |
| 10 | 1989 | 11 | |
| 11 | 1986 | 99 | |
| 12 | 1986 | 10 | |
| 13 | 1985 | 1 | |
| 14 | 1984 | 164 | |
| 15 | 1982 | 152 | |
| 16 | 1981 | 7 | |
| 17 | Irreversible protein binding of [14C]-practolol metabolite(s) to hamster liver microsomes (proceedings). | 1977 | 1 |
| 18 | 1975 | 32 | |
| 19 | 1974 | 80 | |
| 20 | 1973 | 85 |
About T.C. Orton
T.C. Orton is a scholar working on Pharmacology, Developmental Neuroscience and Oncology, having authored 40 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (11 papers), Drug Transport and Resistance Mechanisms (5 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Hormonal Regulation and Hypertension (3 papers), Pluripotent Stem Cells Research (3 papers), Cancer Treatment and Pharmacology (3 papers), Ion channel regulation and function (3 papers) and Estrogen and related hormone effects (3 papers). The work is most often cited by research in Pharmacology (292 citations), Cancer Research (271 citations) and Health, Toxicology and Mutagenesis (205 citations). T.C. Orton has collaborated with scholars based in United Kingdom, United States and Singapore. Frequent co-authors include Oliver Flint, Thomas E. Eling, M. Anderson, R.D. Pickett, Peter Greaves, Graham R. Nunn, J.C. Topham, Robert L. Fine, M. Kay Washington and Gerald R. Hankins. Their work appears in journals such as Carcinogenesis, Journal of Pharmacology and Experimental Therapeutics, Xenobiotica, Food and Chemical Toxicology and Toxicology in Vitro.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.